Login / Signup

Effects of denosumab on bone mineral density and bone metabolism in patients with end-stage renal disease: A systematic review and meta-analysis.

Zhaoyan GuXuhui YangYan WangJian-Jun Gao
Published in: Hemodialysis international. International Symposium on Home Hemodialysis (2023)
Denosumab increased the BMDs of the lumbar spine and femoral neck in patients with ESRD. The onset of hypocalcemia must be carefully monitored during denosumab administration.
Keyphrases
  • bone mineral density
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • postmenopausal women
  • body composition